Compare · EUCR vs PNTM
EUCR vs PNTM
Side-by-side comparison of Eucrates Biomedical Acquisition Corp. (EUCR) and Pontem Corporation (PNTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUCR and PNTM operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM is the larger of the two at $838.8M, about 6.4x EUCR ($131.6M).
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits